guanfacine (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the guanfacine drug offered from Actavis Pharma, Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | guanfacine |
SUBSTANCE NAME: | GUANFACINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-12-01 |
END MARKETING DATE: | 0000-00-00 |
guanfacine HUMAN PRESCRIPTION DRUG Details:
Item Description | guanfacine from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2014-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0228-2850_c5eeae05-2b54-4404-913d-cd2a5eb0477f |
PRODUCT NDC: | 0228-2850 |
APPLICATION NUMBER: | ANDA200881 |
Other GUANFACINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: